Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
News Article updated on 10/01/2021
-
PACHA to Meet in November
PACHA, the Presidential Advisory Council on HIV/AIDS, will convene again on November 15 and again on Nov
News Article updated on 10/14/2021 -
EHE Jurisdictional Directory
List of local and state EHE points of contact.Resource updated 03/28/2024
-
Completing the EHE Triannual Module PROVIDER Report
Instructions for completing the EHE Triannual Provider Report.Resource updated 06/11/2024
-
Social Determinants of Health Added to EHE AHEAD Dashboard
-
Hybrid Format for Ryan White 2022
Next year’s Ryan White Conference will adopt an in-person/virtual format, while the Clinica
News Article updated on 10/15/2021 -
EHE Resource Recap, October 2021
HHS has funded multiple agencies to deliver technical assistance and training to Ending the HIV Epid
News Article updated on 10/18/2021 -
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
HRSA EHE Quarterly Recipient Webinars
These sessions provide HRSA-HAB funded EHE recipients the opportunity to learn about updates with the initiative, review data trends, and a means to share their EHE activities with their counterparts.Resource updated 06/13/2024
-
HRSA Funding Opportunity: HIV Prevention for Health Centers
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
Leveraging Collaboration between the RWHAP and Aging Agencies: Enhancing Support Services for Older Adults with HIV
This HRSA’s HIV/AIDS Bureau (HAB) webinar, in collaboration with Administration for Community Living (ACL), featured presenters from ACL and USAging.Resource updated 01/26/2022
-
HRSA Funding Opportunities: Improving Health Outcomes for People Aging with HIV
From HRSA's HIV/AIDS Bureau
News Article updated on 10/28/2021 -
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Managing Aging and HIV
Review of key components of Geriatric Assessment through the 5Ms framework; practical assessment tools for cognitive impairment and falls; and strategies to ask and address social isolation and loneliness.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024